Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients

Lignende værker

• The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients
  af: Arnaud Del Bello, et al.
  Udgivet: (2024-06-01)
• Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
  af: El Sakhawi, Karim, et al.
  Udgivet: (2020)
• Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale
  af: Chandran, Sindhu, et al.
  Udgivet: (2020)
• Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate
  af: Belliere, Julie, et al.
  Udgivet: (2014)
• Specific organization for in-hospital belatacept infusion to avoid nosocomial transmission during the SARS-CoV-2 pandemic
  af: Kamar, Nassim, et al.
  Udgivet: (2020)